Skip to main content

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index] [List Home]
RE: [epf-dev] Upgrade to EPF Composer 1.5

Hi Ricardo,
 
I guess creating new elements, deleting elements, or moving elements between plug-ins are also forbidden?  How long with this constraint be in place?
 
Cheers,
Chris


From: epf-dev-bounces@xxxxxxxxxxx [mailto:epf-dev-bounces@xxxxxxxxxxx] On Behalf Of Ricardo Balduino
Sent: Monday, May 12, 2008 12:59 PM
To: epf-dev@xxxxxxxxxxx
Subject: [epf-dev] Upgrade to EPF Composer 1.5


Hi,

We are now using the EPF Composer 1.5 M2 to author content.

Committers and contributors doing work on the Practice library, please upgrade to this version. You can download it from:
http://www.eclipse.org/downloads/download.php?file=/technology/epf/composer/nightly/epf-composer-1.5.0M2-N20080508-0800-win32.zip

There is still some work in progress. For now, please restrict any updates you do to text changes.
Please, do not make any updates that affect plugin.xmi files - no brief description or presentation name changes.
I will send out a note when all the remaining changes are complete.

Also, find attached a quick guide on setting up access to CVS. This document also includes good tips for anyone new to working with CVS and Bugzilla.

 

Thank you,

Ricardo Balduino.

--------------------------------------------------------------------------------
Telelogic, An IBM Company
Learn More at www.telelogic.com


Chris Sibbald
Senior Systems Engineer
Telelogic An IBM Company
255 Albert Street, Suite 600
Ottawa, Ontario K1P 6A9
Canada

Phone: +1 (613) 266 5061
Fax: +1 (613) 482 4538
Mobile phone:+1 (613) 266 5061

Chris.Sibbald@xxxxxxxxxxxxx
http://www.telelogic.com

Telelogic Lifecycle Solutions:
Helping You Define, Design & Deliver Advanced Systems & Software

-------------------------------------------------------------


The information contained in this e-mail, including any attachment or enclosure, is intended only for the person or entity to which it is addressed and may contain confidential material. Any unauthorized use, review, retransmissions, dissemination, copying or other use of this information by persons or entities other than the intended recipient is prohibited.


Back to the top